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Background: In atherosclerosis, oxidative stress amplifies the inflammatory response and contributes to plaque vulnerability. We hypothesized 
that the NADPH oxidase inhibitor apocynin would reduce endothelial activation thereby reducing plaque severity. To test this hypothesis contrast 
enhanced ultrasound (CEU) molecular imaging of endothelial cell adhesion molecules (ECAMs) and platelets was used in a murine model of 
advanced atherosclerosis.
Methods: Atherosclerotic mice deficient for the LDL receptor and Apobec-1-/- were studied at 30 weeks of age and 10 weeks later with or without 
Apocynin treatment (either 10 or 50 mg/kg/day orally). CEU molecular imaging of the thoracic aorta was performed using microbubbles targeted 
to ECAMs (VCAM-1or P-selectin) and to platelet GP1b. Aortic mechanical properties (elastic modulus [EM] and aortic pulse transit time [PTT]) were 
assessed using high-frequency ultrasound and invasive hemodynamics. Plaque area and monocytes were assessed by histology.
Results: Untreated control animals had a two-fold increase in signal for P-selectin, VCAM-1 and platelets between 30 and 40 wks, indicating 
age-dependent increase in inflammation. Low-dose apocynin produced a 20-30% decrease in signal for P-selectin, VCAM-1 and platelets at 40 
wks compared to controls (p<0.05 for all). High-dose apocynin reduced signal for P-selectin, VCAM-1 and platelets by 50% (p<0.05) to a level 
similar to that measured at 30 wks. Apocynin decreased the EM (0.50±0.12, 0.39±0.07 and 0.31±0.12 105 N.m-2 for control, low- and high-dose, 
respectively) and increased the PTT (22±2, 24±1, and 29±3 ms for control, low- and high-dose, respectively). On histology, apocynin reduced the 
monocyte infiltration in the dose-dependent manner, although plaque area was reduced in only the high dose group.
Conclusions: Inhibition of NADPH oxidase in advanced atherosclerosis reduces endothelial activation and platelet adhesion; thereby slowing 
plaque growth, reducing inflammation and improving the vascular mechanical properties. Our results also suggest that CEU molecular imaging may 
be a powerful method for assessing therapeutic interventions aimed at reducing plaque inflammation
